- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 87 | 1.16 | 1.16 | 0.32 | 39.13 | 255.56 | 0.40 | 81.82 | 90.48 | 1.07 | 42.67 | 91.07 | 5.01 | -0.99 | 5.47 | 51.66 | -1.62 | -1.79 | 11.58 | 56.49 | 28.81 | 5.53 | 39.29 | 243.48 | 0.58 | 56.76 | 34.88 | 0.28 | 40.0 | 250.0 | 10.24 | 35.99 | 50.15 | 5.53 | 39.29 | 243.48 | 0.20 | -7.88 | 26.39 |
| 24Q2 (19) | 86 | 0.0 | 0.0 | 0.23 | -54.9 | 15.0 | 0.22 | -29.03 | -26.67 | 0.75 | 47.06 | 59.57 | 5.06 | 1.4 | 7.66 | 52.51 | -6.37 | 0.98 | 7.40 | -34.11 | -23.32 | 3.97 | -54.78 | 8.17 | 0.37 | -33.93 | -17.78 | 0.2 | -54.55 | 17.65 | 7.53 | -48.71 | -3.21 | 3.97 | -54.78 | 8.17 | -2.13 | -4.59 | -29.29 |
| 24Q1 (18) | 86 | 0.0 | 0.0 | 0.51 | 45.71 | 96.15 | 0.31 | -29.55 | 272.22 | 0.51 | -43.33 | 96.15 | 4.99 | -5.67 | 22.0 | 56.08 | 13.0 | 5.1 | 11.23 | 3.89 | 295.42 | 8.78 | 56.79 | 58.2 | 0.56 | -1.75 | 366.67 | 0.44 | 46.67 | 91.3 | 14.68 | 56.5 | 19.54 | 8.78 | 56.79 | 58.2 | 2.85 | 167.30 | 39.98 |
| 23Q4 (17) | 86 | 0.0 | 0.0 | 0.35 | 288.89 | 131.25 | 0.44 | 109.52 | 100.0 | 0.90 | 60.71 | -57.75 | 5.29 | 11.37 | 13.03 | 49.63 | -5.65 | -11.63 | 10.81 | 20.24 | 84.16 | 5.60 | 247.83 | 127.18 | 0.57 | 32.56 | 111.11 | 0.3 | 275.0 | 131.25 | 9.38 | 37.54 | 150.08 | 5.60 | 247.83 | 127.18 | 6.21 | 116.94 | 39.76 |
| 23Q3 (16) | 86 | 0.0 | 0.0 | 0.09 | -55.0 | -90.11 | 0.21 | -30.0 | -72.37 | 0.56 | 19.15 | -82.77 | 4.75 | 1.06 | -28.25 | 52.60 | 1.15 | 0.73 | 8.99 | -6.84 | -45.68 | 1.61 | -56.13 | -86.34 | 0.43 | -4.44 | -60.55 | 0.08 | -52.94 | -89.74 | 6.82 | -12.34 | -62.91 | 1.61 | -56.13 | -86.34 | 7.99 | -39.04 | 118.34 |
| 23Q2 (15) | 86 | 0.0 | 0.0 | 0.20 | -23.08 | -89.36 | 0.30 | 266.67 | -83.33 | 0.47 | 80.77 | -79.91 | 4.7 | 14.91 | -42.33 | 52.00 | -2.55 | -10.87 | 9.65 | 239.79 | -65.79 | 3.67 | -33.87 | -81.45 | 0.45 | 275.0 | -80.43 | 0.17 | -26.09 | -89.44 | 7.78 | -36.64 | -72.84 | 3.67 | -33.87 | -81.45 | 1.15 | 50.06 | 42.43 |
| 23Q1 (14) | 86 | 0.0 | 0.0 | 0.26 | 123.21 | -43.48 | -0.18 | -181.82 | -175.0 | 0.26 | -87.79 | -43.48 | 4.09 | -12.61 | -10.11 | 53.36 | -4.99 | 3.17 | 2.84 | -51.62 | -72.64 | 5.55 | 126.94 | -36.21 | 0.12 | -55.56 | -74.47 | 0.23 | 123.96 | -42.5 | 12.28 | 165.56 | -15.31 | 5.55 | 126.94 | -36.21 | -20.96 | -49.94 | -126.44 |
| 22Q4 (13) | 86 | 0.0 | 8.86 | -1.12 | -223.08 | -1766.67 | 0.22 | -71.05 | 257.14 | 2.13 | -34.46 | 61.36 | 4.68 | -29.31 | 0.65 | 56.16 | 7.55 | 32.45 | 5.87 | -64.53 | 61.26 | -20.60 | -274.72 | -1807.41 | 0.27 | -75.23 | 58.82 | -0.96 | -223.08 | -1820.0 | -18.73 | -201.85 | -467.25 | -20.60 | -274.72 | -1807.41 | -24.04 | -137.34 | -64.41 |
| 22Q3 (12) | 86 | 0.0 | 11.69 | 0.91 | -51.6 | 18.18 | 0.76 | -57.78 | 33.33 | 3.25 | 38.89 | 128.87 | 6.62 | -18.77 | 25.14 | 52.22 | -10.49 | 3.96 | 16.55 | -41.33 | 30.52 | 11.79 | -40.39 | 4.24 | 1.09 | -52.61 | 62.69 | 0.78 | -51.55 | 30.0 | 18.39 | -35.81 | 26.48 | 11.79 | -40.39 | 4.24 | 30.18 | 128.55 | 296.11 |
| 22Q2 (11) | 86 | 0.0 | 11.69 | 1.88 | 308.7 | 93.81 | 1.80 | 650.0 | 133.77 | 2.34 | 408.7 | 260.0 | 8.15 | 79.12 | 52.91 | 58.34 | 12.8 | 11.55 | 28.21 | 171.77 | 81.77 | 19.78 | 127.36 | 41.89 | 2.3 | 389.36 | 177.11 | 1.61 | 302.5 | 117.57 | 28.65 | 97.59 | 70.64 | 19.78 | 127.36 | 41.89 | 38.48 | 587.68 | 460.72 |
| 22Q1 (10) | 86 | 8.86 | 11.69 | 0.46 | 866.67 | 243.75 | 0.24 | 271.43 | 209.09 | 0.46 | -65.15 | 243.75 | 4.55 | -2.15 | 21.66 | 51.72 | 21.98 | 13.55 | 10.38 | 185.16 | 2761.54 | 8.70 | 905.56 | 231.22 | 0.47 | 176.47 | 4800.0 | 0.4 | 900.0 | 260.0 | 14.50 | 184.31 | 817.82 | 8.70 | 905.56 | 231.22 | -7.12 | 379.44 | 73.44 |
| 21Q4 (9) | 79 | 2.6 | 2.6 | -0.06 | -107.79 | -112.24 | -0.14 | -124.56 | -131.11 | 1.32 | -7.04 | 266.67 | 4.65 | -12.1 | -9.36 | 42.40 | -15.59 | -21.16 | 3.64 | -71.29 | -64.69 | -1.08 | -109.55 | -114.71 | 0.17 | -74.63 | -67.92 | -0.05 | -108.33 | -113.16 | 5.10 | -64.92 | -49.55 | -1.08 | -109.55 | -114.71 | -6.42 | -64.20 | -75.27 |
| 21Q3 (8) | 77 | 0.0 | 0.0 | 0.77 | -20.62 | 2025.0 | 0.57 | -25.97 | 470.0 | 1.42 | 118.46 | 1192.31 | 5.29 | -0.75 | 37.05 | 50.23 | -3.96 | -1.8 | 12.68 | -18.3 | 98.12 | 11.31 | -18.87 | 1608.0 | 0.67 | -19.28 | 168.0 | 0.6 | -18.92 | 2100.0 | 14.54 | -13.4 | 325.15 | 11.31 | -18.87 | 1608.0 | 20.88 | 191.25 | 212.01 |
| 21Q2 (7) | 77 | 0.0 | 1.32 | 0.97 | 403.12 | 1070.0 | 0.77 | 450.0 | 1383.33 | 0.65 | 303.12 | 822.22 | 5.33 | 42.51 | 62.01 | 52.30 | 14.82 | 1.47 | 15.52 | 4079.49 | 349.86 | 13.94 | 310.26 | 703.46 | 0.83 | 8400.0 | 654.55 | 0.74 | 396.0 | 1025.0 | 16.79 | 931.19 | 590.95 | 13.94 | 310.26 | 703.46 | 7.70 | 118.91 | 150.56 |
| 21Q1 (6) | 77 | 0.0 | 0.0 | -0.32 | -165.31 | -3300.0 | -0.22 | -148.89 | 0 | -0.32 | -188.89 | -3300.0 | 3.74 | -27.1 | 9.68 | 45.55 | -15.3 | -9.35 | -0.39 | -103.78 | -108.57 | -6.63 | -190.33 | -3257.14 | -0.01 | -101.89 | -106.67 | -0.25 | -165.79 | -2600.0 | -2.02 | -119.98 | -142.08 | -6.63 | -190.33 | -3257.14 | 2.90 | 579.85 | 100.56 |
| 20Q4 (5) | 77 | 0.0 | 0.0 | 0.49 | 1325.0 | -33.78 | 0.45 | 350.0 | -32.84 | 0.36 | 376.92 | -82.86 | 5.13 | 32.9 | 10.09 | 53.78 | 5.14 | -0.76 | 10.31 | 61.09 | -30.81 | 7.34 | 1078.67 | -39.93 | 0.53 | 112.0 | -23.19 | 0.38 | 1366.67 | -33.33 | 10.11 | 195.61 | -30.85 | 7.34 | 1078.67 | -39.93 | - | - | 0.00 |
| 20Q3 (4) | 77 | 1.32 | 0.0 | -0.04 | 60.0 | 0.0 | 0.10 | 266.67 | 0.0 | -0.13 | -44.44 | 0.0 | 3.86 | 17.33 | 0.0 | 51.15 | -0.76 | 0.0 | 6.40 | 85.51 | 0.0 | -0.75 | 67.53 | 0.0 | 0.25 | 127.27 | 0.0 | -0.03 | 62.5 | 0.0 | 3.42 | 40.74 | 0.0 | -0.75 | 67.53 | 0.0 | - | - | 0.00 |
| 20Q2 (3) | 76 | -1.3 | 0.0 | -0.10 | -1100.0 | 0.0 | -0.06 | 0 | 0.0 | -0.09 | -1000.0 | 0.0 | 3.29 | -3.52 | 0.0 | 51.54 | 2.57 | 0.0 | 3.45 | -24.18 | 0.0 | -2.31 | -1200.0 | 0.0 | 0.11 | -26.67 | 0.0 | -0.08 | -900.0 | 0.0 | 2.43 | -49.38 | 0.0 | -2.31 | -1200.0 | 0.0 | - | - | 0.00 |
| 20Q1 (2) | 77 | 0.0 | 0.0 | 0.01 | -98.65 | 0.0 | 0.00 | -100.0 | 0.0 | 0.01 | -99.52 | 0.0 | 3.41 | -26.82 | 0.0 | 50.25 | -7.27 | 0.0 | 4.55 | -69.46 | 0.0 | 0.21 | -98.28 | 0.0 | 0.15 | -78.26 | 0.0 | 0.01 | -98.25 | 0.0 | 4.80 | -67.17 | 0.0 | 0.21 | -98.28 | 0.0 | - | - | 0.00 |
| 19Q4 (1) | 77 | 0.0 | 0.0 | 0.74 | 0.0 | 0.0 | 0.67 | 0.0 | 0.0 | 2.10 | 0.0 | 0.0 | 4.66 | 0.0 | 0.0 | 54.19 | 0.0 | 0.0 | 14.90 | 0.0 | 0.0 | 12.22 | 0.0 | 0.0 | 0.69 | 0.0 | 0.0 | 0.57 | 0.0 | 0.0 | 14.62 | 0.0 | 0.0 | 12.22 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 1.3 | -0.44 | -7.62 | 16.37 | 9.57 | 5.02 | N/A | - | ||
| 2024/9 | 1.31 | -45.5 | 13.22 | 15.07 | 11.37 | 5.24 | 1.03 | - | ||
| 2024/8 | 2.4 | 57.87 | -1.5 | 13.76 | 11.19 | 5.18 | 1.04 | - | ||
| 2024/7 | 1.52 | 21.11 | 32.48 | 11.36 | 14.32 | 5.12 | 1.05 | - | ||
| 2024/6 | 1.26 | -46.31 | -0.06 | 9.84 | 11.94 | 4.84 | 1.1 | - | ||
| 2024/5 | 2.34 | 88.44 | 3.9 | 8.58 | 13.95 | 4.81 | 1.11 | - | ||
| 2024/4 | 1.24 | 1.65 | 4.44 | 6.24 | 18.24 | 4.74 | 1.12 | - | ||
| 2024/3 | 1.22 | -46.39 | 1.52 | 4.99 | 22.26 | 4.99 | 1.08 | - | ||
| 2024/2 | 2.28 | 52.77 | 15.08 | 3.77 | 30.93 | 5.15 | 1.05 | - | ||
| 2024/1 | 1.49 | 8.51 | 65.8 | 1.49 | 65.8 | 5.37 | 1.0 | 主要係去年1月春節假期9天,實際工作天少;另逢1月流感季節，客戶對本公司產品需求大增，致合併營收較去年同期增加。 | ||
| 2023/12 | 1.38 | -44.97 | 5.44 | 18.82 | -21.54 | 5.29 | 1.02 | - | ||
| 2023/11 | 2.5 | 77.09 | 10.79 | 17.44 | -23.09 | 5.07 | 1.06 | - | ||
| 2023/10 | 1.41 | 22.03 | 26.39 | 14.94 | -26.84 | 5.01 | 1.07 | - | ||
| 2023/9 | 1.16 | -52.6 | -26.23 | 13.53 | -29.91 | 4.75 | 1.24 | - | ||
| 2023/8 | 2.44 | 112.36 | -29.36 | 12.38 | -30.24 | 4.85 | 1.22 | - | ||
| 2023/7 | 1.15 | -8.64 | -27.86 | 9.94 | -30.45 | 4.66 | 1.26 | - | ||
| 2023/6 | 1.26 | -44.18 | -48.17 | 8.79 | -30.78 | 4.7 | 1.21 | - | ||
| 2023/5 | 2.25 | 89.42 | -41.99 | 7.53 | -26.67 | 4.65 | 1.22 | - | ||
| 2023/4 | 1.19 | -1.18 | -35.22 | 5.27 | -17.34 | 4.37 | 1.3 | - | ||
| 2023/3 | 1.2 | -39.23 | -14.13 | 4.09 | -10.12 | 4.09 | 1.44 | - | ||
| 2023/2 | 1.98 | 120.1 | 1.76 | 2.88 | -8.33 | 4.19 | 1.41 | - | ||
| 2023/1 | 0.9 | -30.98 | -24.77 | 0.9 | -24.77 | 4.46 | 1.32 | - | ||
| 2022/12 | 1.3 | -42.18 | -6.56 | 23.99 | 26.16 | 4.68 | 1.17 | - | ||
| 2022/11 | 2.26 | 102.02 | 7.44 | 22.68 | 28.75 | 4.94 | 1.11 | - | ||
| 2022/10 | 1.12 | -28.77 | -2.88 | 20.43 | 31.64 | 6.14 | 0.89 | - | ||
| 2022/9 | 1.57 | -54.61 | 11.33 | 19.31 | 34.4 | 6.62 | 0.81 | - | ||
| 2022/8 | 3.45 | 116.88 | 58.77 | 17.74 | 36.91 | 7.47 | 0.71 | 主係檢驗試劑部門和其他部門之產品，市場需求增加，致整體營收增加。 | ||
| 2022/7 | 1.59 | -34.36 | -6.81 | 14.29 | 32.5 | 7.9 | 0.68 | - | ||
| 2022/6 | 2.43 | -37.52 | 35.11 | 12.69 | 39.91 | 8.15 | 0.68 | - | ||
| 2022/5 | 3.88 | 111.51 | 52.78 | 10.27 | 41.09 | 7.12 | 0.78 | 主係檢驗試劑部門和其他部門之產品，市場需求增加，致整體營收增加。 | ||
| 2022/4 | 1.84 | 30.98 | 84.86 | 6.38 | 34.81 | 5.19 | 1.08 | 主係檢驗試劑部門和其他部門之產品，市場需求增加，致整體營收增加。 | ||
| 2022/3 | 1.4 | -27.98 | 26.68 | 4.55 | 21.52 | 4.55 | 1.19 | - | ||
| 2022/2 | 1.95 | 62.69 | 15.26 | 3.14 | 19.35 | 4.54 | 1.19 | - | ||
| 2022/1 | 1.2 | -14.27 | 26.67 | 1.2 | 26.67 | 4.69 | 1.16 | - | ||
| 2021/12 | 1.4 | -33.52 | -18.89 | 19.01 | 21.2 | 4.65 | 1.14 | - | ||
| 2021/11 | 2.1 | 82.6 | -1.85 | 17.62 | 26.14 | 4.66 | 1.14 | - | ||
| 2021/10 | 1.15 | -18.34 | -0.1 | 15.52 | 31.2 | 4.73 | 1.12 | - | ||
| 2021/9 | 1.41 | -35.27 | 9.04 | 14.37 | 34.58 | 5.29 | 1.08 | - | ||
| 2021/8 | 2.18 | 27.29 | 31.07 | 12.96 | 38.1 | 5.68 | 1.01 | - | ||
| 2021/7 | 1.71 | -4.83 | 66.01 | 10.78 | 39.61 | 6.05 | 0.94 | 主係新冠肺炎疫情，檢驗試劑及感控部門之產品，市場需求增加，及新併入之子公司營收，致整體營收增加。 | ||
| 2021/6 | 1.8 | -29.34 | 125.5 | 9.07 | 35.54 | 5.33 | 1.09 | 主係新冠肺炎疫情，檢驗試劑及感控部門之產品，市場需求增加，致整體營收增加。 | ||
| 2021/5 | 2.54 | 155.92 | 67.32 | 7.28 | 23.39 | 4.64 | 1.25 | 主係新冠肺炎疫情，檢驗試劑及感控部門之產品，市場需求增加，致整體營收增加。 | ||
| 2021/4 | 0.99 | -10.24 | 2.3 | 4.73 | 8.15 | 3.79 | 1.53 | - | ||
| 2021/3 | 1.11 | -34.46 | 14.17 | 3.74 | 9.81 | 3.74 | 1.57 | - | ||
| 2021/2 | 1.69 | 78.79 | 3.2 | 2.63 | 8.08 | 4.35 | 1.35 | - | ||
| 2021/1 | 0.94 | -45.11 | 18.07 | 0.94 | 18.07 | 4.81 | 1.23 | - | ||
| 2020/12 | 1.72 | -19.55 | 6.61 | 15.69 | -0.33 | 5.01 | 1.12 | - | ||
| 2020/11 | 2.14 | 85.85 | 8.69 | 13.97 | -1.13 | 4.58 | 1.22 | - | ||
| 2020/10 | 1.15 | -10.87 | 7.98 | 11.83 | -2.72 | 4.1 | 1.37 | - | ||
| 2020/9 | 1.29 | -22.19 | 25.46 | 10.67 | -3.75 | 3.98 | 1.1 | - | ||
| 2020/8 | 1.66 | 61.22 | 1.11 | 9.38 | -6.74 | 3.49 | 1.26 | - | ||
| 2020/7 | 1.03 | 29.26 | 23.06 | 7.72 | -8.27 | 3.35 | 1.31 | - | ||
| 2020/6 | 0.8 | -47.57 | -14.87 | 6.69 | -11.73 | 3.29 | 1.22 | - | ||
| 2020/5 | 1.52 | 56.47 | -8.82 | 5.9 | -11.28 | 3.46 | 1.16 | - | ||
| 2020/4 | 0.97 | 0.17 | -30.94 | 4.38 | -12.11 | 3.58 | 1.12 | - | ||
| 2020/3 | 0.97 | -40.76 | -9.42 | 3.41 | -4.7 | 3.41 | 1.08 | - | ||
| 2020/2 | 1.64 | 104.56 | 14.17 | 2.44 | -2.68 | 4.05 | 0.91 | - | ||
| 2020/1 | 0.8 | -50.44 | -25.27 | 0.8 | -25.27 | 4.38 | 0.84 | - | ||
| 2019/12 | 1.61 | -17.98 | 24.36 | 15.74 | 11.81 | 0.0 | N/A | - | ||
| 2019/11 | 1.97 | 84.63 | 8.49 | 14.13 | 10.53 | 0.0 | N/A | - |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 86 | 0.0 | 0.90 | -57.55 | 0.75 | -75.17 | 18.82 | -21.55 | 51.78 | -5.8 | 8.33 | -51.74 | 4.10 | -46.05 | 1.57 | -62.08 | 1.69 | -49.25 | 0.77 | -57.69 |
| 2022 (9) | 86 | 8.86 | 2.12 | 60.61 | 3.02 | 202.0 | 23.99 | 26.2 | 54.97 | 14.57 | 17.26 | 98.39 | 7.60 | 38.43 | 4.14 | 150.91 | 3.33 | 81.97 | 1.82 | 75.0 |
| 2021 (8) | 79 | 2.6 | 1.32 | 266.67 | 1.00 | 104.08 | 19.01 | 21.16 | 47.98 | -7.54 | 8.70 | 30.63 | 5.49 | 208.43 | 1.65 | 57.14 | 1.83 | 105.62 | 1.04 | 271.43 |
| 2020 (7) | 77 | 0.0 | 0.36 | -82.86 | 0.49 | -73.22 | 15.69 | -0.32 | 51.89 | -5.5 | 6.66 | -53.2 | 1.78 | -82.63 | 1.05 | -53.12 | 0.89 | -60.62 | 0.28 | -82.61 |
| 2019 (6) | 77 | 1.32 | 2.10 | 0.96 | 1.83 | 25.34 | 15.74 | 11.71 | 54.91 | -3.72 | 14.23 | -5.7 | 10.25 | -9.29 | 2.24 | 5.16 | 2.26 | -7.38 | 1.61 | 1.26 |
| 2018 (5) | 76 | 11.76 | 2.08 | 56.39 | 1.46 | 36.45 | 14.09 | 16.25 | 57.03 | -0.42 | 15.09 | 26.38 | 11.30 | 51.27 | 2.13 | 46.9 | 2.44 | 70.63 | 1.59 | 74.73 |
| 2017 (4) | 68 | 9.68 | 1.33 | -8.28 | 1.07 | 3.88 | 12.12 | 15.54 | 57.27 | 2.1 | 11.94 | -3.32 | 7.47 | -12.63 | 1.45 | 11.54 | 1.43 | 10.85 | 0.91 | 1.11 |
| 2016 (3) | 62 | 10.71 | 1.45 | 11.54 | 1.03 | 15.73 | 10.49 | -12.95 | 56.09 | -8.15 | 12.35 | 24.0 | 8.55 | 41.09 | 1.3 | 8.33 | 1.29 | 11.21 | 0.9 | 23.29 |
| 2015 (2) | 56 | 16.67 | 1.30 | 31.31 | 0.89 | 102.27 | 12.05 | 18.84 | 61.07 | 1.72 | 9.96 | 56.85 | 6.06 | 29.49 | 1.2 | 87.5 | 1.16 | 54.67 | 0.73 | 52.08 |
| 2014 (1) | 48 | 26.32 | 0.99 | 115.22 | 0.44 | 340.0 | 10.14 | 18.32 | 60.04 | 0 | 6.35 | 0 | 4.68 | 0 | 0.64 | 357.14 | 0.75 | 226.09 | 0.48 | 166.67 |
